Co-targeting of Akt and Myc inhibits viability of lymphoma cells from Lck-Dlx5 mice.
about
Targeting MYC Dependence by Metabolic Inhibitors in CancerInhibition of c-MYC with involvement of ERK/JNK/MAPK and AKT pathways as a novel mechanism for shikonin and its derivatives in killing leukemia cells.Treating Burkitt Lymphoma in Adults.Targeting MYC sensitizes malignant mesothelioma cells to PAK blockage-induced cytotoxicity.The homeoprotein Dlx5 drives murine T-cell lymphomagenesis by directly transactivating Notch and upregulating Akt signaling.
P2860
Co-targeting of Akt and Myc inhibits viability of lymphoma cells from Lck-Dlx5 mice.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Co-targeting of Akt and Myc inhibits viability of lymphoma cells from Lck-Dlx5 mice.
@ast
Co-targeting of Akt and Myc inhibits viability of lymphoma cells from Lck-Dlx5 mice.
@en
type
label
Co-targeting of Akt and Myc inhibits viability of lymphoma cells from Lck-Dlx5 mice.
@ast
Co-targeting of Akt and Myc inhibits viability of lymphoma cells from Lck-Dlx5 mice.
@en
prefLabel
Co-targeting of Akt and Myc inhibits viability of lymphoma cells from Lck-Dlx5 mice.
@ast
Co-targeting of Akt and Myc inhibits viability of lymphoma cells from Lck-Dlx5 mice.
@en
P2093
P2860
P1476
Co-targeting of Akt and Myc inhibits viability of lymphoma cells from Lck-Dlx5 mice.
@en
P2093
Eleonora Sementino
Jianming Pei
Joseph R Testa
Timothy K Ito
Yinfei Tan
Yuwaraj Kadariya
P2860
P304
P356
10.1080/15384047.2015.1018495
P577
2015-03-20T00:00:00Z